Deep Track Capital, LP — 13F Holdings

2026 Q3  ·  87 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Deep Track Capital, LP maintained a portfolio of 87 distinct positions. The most significant new addition was INSMED INC, now representing 2.51% of the total fund value. They heavily accumulated shares in BIOMARIN PHARMACEUTICAL INC, increasing the position by 92.7%. Conversely, Deep Track Capital, LP completely exited their position in ALNYLAM PHARMACEUTICALS INC.
Position History hover any row below to update
Loading…
Deep Track Capital, LP New York, NY Hedge Fund AUM $5,943M
PCA Score Concentration Risk
Risk ENB
Total Positions
87
Quarter
2026 Q3
Top Holding
GH (8.2%)
Top 10 Concentration
43.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 87

Deep Track Capital, LP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
GH
GUARDANT HEALTH...
Healthcare 8.15% 7.41% #1
Prev: #1
5.8
—
-587,635 -17.3%
P
S
2,805,677 $500,420,550
$32.99 +334.4%
$178.36 -19.7%
2023 Q2 13F Filing 2026-09-30 2026-11-16
BMRN
BIOMARIN PHARMA...
Healthcare 6.23% 2.75% #2 9
Prev: #11
7.0
—
3,066,914 92.7%
P
S
6,374,395 $382,463,700 2022 Q2 13F Filing 2026-09-30 2026-11-16
IMVT
IMMUNOVANT INC
Healthcare 5.04% 5.24% #3 1
Prev: #2
3.5
—
-180,350 -1.9%
P
S
9,160,801 $309,451,858 2021 Q4 13F Filing 2026-09-30 2026-11-16
TARS
TARSUS PHARMACE...
Healthcare 4.87% 3.36% #4 3
Prev: #7
2.9
—
140,000 3.8%
P
S
3,806,768 $299,250,032 2025 Q1 13F Filing 2026-09-30 2026-11-16
MANE
VERADERMICS INC
Healthcare 3.75% 3.58% #5 1
Prev: #6
2.5
—
-100,000 -5.0%
P
S
1,900,000 $230,337,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
VERA
VERA THERAPEUTI...
Healthcare 3.68% 2.50% #6 11
Prev: #17
4.5
—
3,000,000 75.0%
P
S
7,000,000 $226,030,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
PCVX
VAXCYTE INC
Healthcare 3.26% 3.64% #7 3
Prev: #4
1.8
—
-786,931 -18.3%
P
S
3,513,069 $199,893,626 2025 Q1 13F Filing 2026-09-30 2026-11-16
ALKS
ALKERMES PLC
Healthcare 2.97% 3.05% #8 1
Prev: #9
3.2
—
500,000 12.5%
P
S
4,500,000 $182,340,000 2023 Q1 13F Filing 2026-09-30 2026-11-16
OCUL
OCULAR THERAPEU...
Healthcare 2.74% 2.81% #9 1
Prev: #10
3.1
—
2,253,343 11.4%
P
S
21,939,625 $168,276,924 2023 Q4 13F Filing 2026-09-30 2026-11-16
UTHR
UNITED THERAPEU...
Healthcare 2.65% 0.97% #10 24
Prev: #34
4.1
—
176,424 142.7%
P
S
300,040 $162,588,676 2026 Q2 13F Filing 2026-09-30 2026-11-16
GPCR
STRUCTURE THERA...
Healthcare 2.55% 3.70% #11 8
Prev: #3
3.0
—
259,928 5.5%
P
S
5,000,000 $156,350,000 2023 Q1 13F Filing 2026-09-30 2026-11-16
GRAL
GRAIL INC
Healthcare 2.52% 1.82% #12 12
Prev: #24
1.0
—
-730,744 -39.8%
P
S
1,104,200 $154,720,504 2025 Q4 13F Filing 2026-09-30 2026-11-16
INSM
INSMED INC
Healthcare 2.51% — #13
Prev: #—
4.5
—
1,350,000 —
NEW
1,350,000 $154,089,000 2022 Q4 13F Filing 2026-09-30 2026-11-16
CMPS
COMPASS PATHWAY...
Healthcare 2.46% 2.50% #14 2
Prev: #16
2.0
—
no change no change
P
S
12,161,496 $151,289,010 2023 Q2 13F Filing 2026-09-30 2026-11-16
GMAB
GENMAB A/S
Healthcare 2.43% 2.26% #15 4
Prev: #19
1.0
—
-1,467,311 -26.0%
P
S
4,182,689 $149,217,430 2024 Q4 13F Filing 2026-09-30 2026-11-16
AXSM
AXSOME THERAPEU...
Healthcare 2.40% 2.49% #16 2
Prev: #18
3.0
—
100,000 14.3%
P
S
800,000 $147,512,000 2023 Q2 13F Filing 2026-09-30 2026-11-16
NRIX
NURIX THERAPEUT...
Healthcare 2.32% 2.73% #17 5
Prev: #12
0.9
—
-1,736,455 -22.4%
P
S
6,000,000 $142,260,000 2022 Q2 13F Filing 2026-09-30 2026-11-16
LBRX
LB PHARMACEUTIC...
Healthcare 2.10% 1.58% #18 10
Prev: #28
1.8
—
no change no change
P
S
3,352,804 $128,680,617 2025 Q3 13F Filing 2026-09-30 2026-11-16
TNGX
TANGO THERAPEUT...
Healthcare 1.83% 1.91% #19 3
Prev: #22
2.7
—
300,000 7.1%
P
S
4,500,000 $112,275,000 2025 Q3 13F Filing 2026-09-30 2026-11-16
MAZE
MAZE THERAPEUTI...
Healthcare 1.81% 1.62% #20 6
Prev: #26
2.7
—
351,400 9.4%
P
S
4,083,969 $111,002,277 2025 Q1 13F Filing 2026-09-30 2026-11-16
COAG
HEMAB THERAPEUT...
Healthcare 1.80% 1.93% #21
Prev: #21
1.2
—
-14,297 -0.4%
P
S
3,587,796 $110,647,629 2026 Q2 13F Filing 2026-09-30 2026-11-16
GMAB
GENMAB A/S
CALL
CALL Option 1.60% 1.20% #22 9
Prev: #31
1.1
—
-240,000 -8.0%
P
S
2,760,000 $98,463,000 2024 Q4 13F Filing 2026-09-30 2026-11-16
MLTX
MOONLAKE IMMUNO...
Healthcare 1.54% 1.98% #23 3
Prev: #20
2.6
—
1,106,265 15.8%
P
S
8,105,290 $94,831,893 2023 Q2 13F Filing 2026-09-30 2026-11-16
ORKA
ORUKA THERAPEUT...
Healthcare 1.45% 2.67% #24 11
Prev: #13
0.6
—
-856,226 -44.5%
P
S
1,069,774 $89,101,476 2024 Q3 13F Filing 2026-09-30 2026-11-16
WGS
GENEDX HOLDINGS...
Healthcare 1.41% 0.70% #25 17
Prev: #42
3.6
—
500,000 71.4%
P
S
1,200,000 $86,760,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
TEM
TEMPUS AI INC
CALL
CALL Option 1.33% — #26
Prev: #—
4.0
—
1,000,000 —
NEW
1,000,000 $81,900,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
COGT
COGENT BIOSCIEN...
Healthcare 1.30% 1.13% #27 5
Prev: #32
3.0
—
500,000 25.0%
P
S
2,500,000 $80,050,000 2024 Q1 13F Filing 2026-09-30 2026-11-16
GHRS
GH RESEARCH PLC
Healthcare 1.27% 1.30% #28 2
Prev: #30
1.5
—
no change no change
P
S
3,333,334 $78,266,682 2021 Q4 13F Filing 2026-09-30 2026-11-16
BCAX
BICARA THERAPEU...
Healthcare 1.24% 1.77% #29 4
Prev: #25
1.5
—
no change no change
P
S
4,100,000 $76,301,000 2024 Q3 13F Filing 2026-09-30 2026-11-16
LTGO
LATIGO BIOTHERA...
Healthcare 1.20% — #30
Prev: #—
4.0
—
4,408,322 —
NEW
4,408,322 $73,618,978 2026 Q3 13F Filing 2026-09-30 2026-11-16
CLDX
CELLDEX THERAPE...
Healthcare 1.12% 1.59% #31 4
Prev: #27
0.4
—
-813,619 -27.7%
P
S
2,125,532 $68,888,492 2024 Q4 13F Filing 2026-09-30 2026-11-16
BBIO
BRIDGEBIO PHARM...
Healthcare 0.95% — #32
Prev: #—
3.9
—
885,882 —
NEW
885,882 $58,291,036 2021 Q4 13F Filing 2026-09-30 2026-11-16
AVTX
AVALO THERAPEUT...
Healthcare 0.90% 0.97% #33 2
Prev: #35
1.4
—
no change no change
P
S
3,610,000 $55,341,300 2024 Q3 13F Filing 2026-09-30 2026-11-16
ALMS
ALUMIS INC
Healthcare 0.90% 2.60% #34 20
Prev: #14
2.4
—
1,121,188 17.7%
P
S
7,469,746 $55,201,423 2026 Q1 13F Filing 2026-09-30 2026-11-16
ALT
ALTIMMUNE INC
Healthcare 0.90% 0.85% #35 3
Prev: #38
1.4
—
no change no change
P
S
19,250,000 $55,055,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
N/A
ATTOVIA THERAPE...
Unknown 0.90% — #36
Prev: #—
3.9
—
3,207,138 —
NEW
3,207,138 $54,970,345 — 13F Filing 2026-09-30 2026-11-16
BLLN
BILLIONTOONE IN...
Healthcare 0.87% — #37
Prev: #—
3.8
—
500,000 —
NEW
500,000 $53,220,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
ACRS
ACLARIS THERAPE...
Healthcare 0.80% 0.72% #38 2
Prev: #40
1.3
—
no change no change
P
S
9,345,000 $49,154,700 2023 Q1 13F Filing 2026-09-30 2026-11-16
CRMD
CORMEDIX INC
Healthcare 0.79% 0.72% #39 2
Prev: #41
1.3
—
no change no change
P
S
6,274,076 $48,310,385 2025 Q3 13F Filing 2026-09-30 2026-11-16
EWTX
EDGEWISE THERAP...
Healthcare 0.76% — #40
Prev: #—
3.8
—
1,148,817 —
NEW
1,148,817 $46,641,970 2022 Q3 13F Filing 2026-09-30 2026-11-16
VSTM
VERASTEM INC
Healthcare 0.75% 0.32% #41 13
Prev: #54
1.3
—
no change no change
P
S
5,740,850 $46,213,843 2025 Q4 13F Filing 2026-09-30 2026-11-16
DFTX
DEFINIUM THERAP...
Healthcare 0.62% 1.88% #42 19
Prev: #23
0.2
—
-1,750,000 -63.6%
P
S
1,000,000 $38,060,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
GENB
GENERATE BIOMED...
Healthcare 0.61% 0.33% #43 10
Prev: #53
3.2
—
1,173,634 88.0%
P
S
2,507,449 $37,661,884 2026 Q2 13F Filing 2026-09-30 2026-11-16
MBX
MBX BIOSCIENCES...
Healthcare 0.61% 1.39% #44 15
Prev: #29
0.2
—
-1,092,569 -63.1%
P
S
640,000 $37,516,800 2024 Q3 13F Filing 2026-09-30 2026-11-16
ANIP
ANI PHARMACEUTI...
Healthcare 0.59% — #45
Prev: #—
3.7
—
500,000 —
NEW
500,000 $36,325,000 2023 Q2 13F Filing 2026-09-30 2026-11-16
VRDN
VIRIDIAN THERAP...
Healthcare 0.57% 0.96% #46 10
Prev: #36
0.2
—
-1,881,710 -52.4%
P
S
1,711,030 $35,230,108 2021 Q4 13F Filing 2026-09-30 2026-11-16
HROW
HARROW INC
Healthcare 0.54% 0.60% #47 4
Prev: #43
2.2
—
100,000 10.3%
P
S
1,069,000 $32,925,200 2026 Q2 13F Filing 2026-09-30 2026-11-16
OBX
OBSIDIAN THERAP...
Healthcare 0.47% — #48
Prev: #—
3.7
—
2,120,050 —
NEW
2,120,050 $29,108,287 2026 Q3 13F Filing 2026-09-30 2026-11-16
CRVS
CORVUS PHARMACE...
Healthcare 0.47% 0.54% #49 5
Prev: #44
1.2
—
no change no change
P
S
2,491,939 $28,707,137 2026 Q1 13F Filing 2026-09-30 2026-11-16
NBIX
NEUROCRINE BIOS...
Healthcare 0.46% — #50
Prev: #—
3.7
—
200,000 —
NEW
200,000 $28,368,000 2023 Q3 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 87 holdings

Unlock Full Deep Track Capital, LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →